Halozyme Therapeutics, Inc. (HALO)
77.31
-2.20
(-2.77%)
USD |
NASDAQ |
Feb 12, 15:49
Halozyme Therapeutics Market Cap : 9.091B for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 591.34B |
| Merck & Co., Inc. | 297.17B |
| AIM ImmunoTech, Inc. | 2.720M |
| Stryker Corp. | 140.13B |
| Skye Bioscience, Inc. | 23.40M |
Market Cap Related Metrics
| PE Ratio | 16.25 |
| PS Ratio | 7.808 |
| PEG Ratio | 0.2829 |
| Price to Book Value | 18.04 |
| Price to Free Cash Flow | 16.11 |
| Price | 77.31 |
| Earnings Yield | 6.15% |
| PEGY Ratio | 0.2829 |
| Operating PE Ratio | 13.16 |
| Normalized PE Ratio | 16.25 |